What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?

被引：0
|
作者：
Eichenauer, Dennis A. [1 ]
Engert, Andreas
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, DE-50937 Cologne, Germany
来源：
ACTA HAEMATOLOGICA | 2015年 / 134卷 / 03期
关键词：
STUDY-GROUP GHSG; PHASE-2;
D O I：
10.1159/000381765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 186
页数：2
相关论文
共 50 条
  • [31] Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate
    Fukawa, Yuki
    Sakamoto, Kei
    Kugimoto, Takuma
    Michi, Yasuyuki
    Harada, Hiroyuki
    Yamamoto, Masahide
    Kitagawa, Masanobu
    Ikeda, Tohru
    Yamamoto, Kouhei
    PATHOLOGY INTERNATIONAL, 2021, 71 (03) : 213 - 215
  • [32] How I treat nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    BLOOD, 2020, 136 (26) : 2987 - 2993
  • [33] Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
    Straus, David J.
    HAEMATOLOGICA, 2021, 106 (10) : 2538 - 2538
  • [34] Autologous Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Popat, Uday
    Hosing, Chitra
    Fanale, Michelle
    Medeiros, L. Jeffrey
    Alousi, Amin M.
    Giralt, Sergio A.
    de Lima, Marcos J.
    Qazilbash, Muzaffar H.
    Kebriaei, Partow
    Younes, Anas
    Khouri, Issa
    Andersson, Borje
    Champlin, Richard
    Anderlini, Paolo
    BLOOD, 2009, 114 (22) : 912 - 912
  • [35] Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma
    Stamatoullas, A.
    Picquenot, J-M
    Dumesnil, C.
    Ruminy, P.
    Penther, D.
    Bertrand, P.
    Courel, M-N
    Maisonneuve, C.
    Francois, A.
    Gaulard, P.
    Tilly, H.
    Bastard, C.
    LEUKEMIA, 2007, 21 (09) : 2064 - 2067
  • [36] Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin’s lymphoma
    Laura Galán
    Antonio C. Sánchez
    Blanca Cantos
    Mariano Provencio
    Clinical and Translational Oncology, 2010, 12 : 384 - 386
  • [37] Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin's lymphoma
    Galan, Laura
    Sanchez, Antonio C.
    Cantos, Blanca
    Provencio, Mariano
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (05): : 384 - 386
  • [38] Rituximab in Lymphocyte-Predominant Hodgkin Disease
    Azim, Hatem A., Jr.
    Pruneri, Giancarlo
    Cocorocchio, Emilia
    Cinieri, Saverio
    Raviele, Paola R.
    Bassi, Simona
    Preda, Lorenzo
    Martinelli, Giovanni
    Peccatori, Fedro A.
    ONCOLOGY, 2009, 76 (01) : 26 - 29
  • [39] Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells
    Seliem R.M.
    Ferry J.A.
    Hasserjian R.P.
    Harris N.L.
    Zukerberg L.R.
    Journal of Hematopathology, 2011, 4 (3) : 175 - 181
  • [40] Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?
    Fanale, Michelle
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 406 - 413
12345